Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interferon α-induced SAMHD1 regulates human cultured megakaryocyte apoptosis and proplatelet formation. | Haematologica | 2022 | 34758609 | PubTator, text mining | PubMed |
| Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma. | Cancer Sci | 2022 | 34751489 | PubTator, text mining | PubMed |
| Identifying the Hub Genes and Immune Cell Infiltration in Synovial Tissue between Osteoarthritic and Rheumatoid Arthritic Patients by Bioinformatic Approach. | Curr Pharm Des | 2022 | 34736376 | PubTator, text mining | PubMed |
| Examining the Hepatic Immune System in Children With Liver Disease With Fine Needle Aspiration. | J Pediatr Gastroenterol Nutr | 2022 | 34732645 | PubTator, text mining | PubMed |
| Clinicopathological analysis of diffuse large B-cell lymphoma lacking surface immunoglobulin light chain restriction on flow cytometry. | J Clin Exp Hematop | 2022 | 34707034 | PubTator, text mining | PubMed |
| Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO): results of a large cohort study. | J Endocrinol Invest | 2022 | 34671950 | PubTator, text mining | PubMed |
| Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma. | Transplant Cell Ther | 2022 | 34670169 | PubTator, text mining | PubMed |
| Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia. | Hematol Oncol | 2022 | 34653277 | PubTator, text mining | PubMed |
| Universal and cross-cancer prognostic biomarkers for predicting survival risk of cancer patients from expression profile of apoptotic pathway genes. | Proteomics | 2022 | 34637591 | PubTator, text mining | PubMed |
| Discovery of Genes that Modulate Flavivirus Replication in an Interferon-Dependent Manner. | J Mol Biol | 2022 | 34599939 | PubTator, text mining | PubMed |
| FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology. | Blood Adv | 2022 | 34587246 | PubTator, text mining | PubMed |
| Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma. | Leukemia | 2022 | 34584203 | PubTator, text mining | PubMed |
| Lymphocytes with auer rod-like inclusions in chronic lymphocytic leukemia. | Hematol Transfus Cell Ther | 2022 | 34580044 | PubTator, text mining | PubMed |
| Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus-Infected Hepatocytes During Interferon Administration. | Hepatol Commun | 2022 | 34558845 | PubTator, text mining | PubMed |
| Hearing loss and tinnitus: association studies for complex-hearing disorders in mouse and man. | Hum Genet | 2022 | 34318347 | PubTator, text mining | PubMed |
| Role of Flow Cytometric Immunophenotyping for Classic Hodgkin Lymphoma in Small Biopsy and Cytology Specimens. | Arch Pathol Lab Med | 2022 | 34293084 | PubTator, text mining | PubMed |
| Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer. | Cancer Immunol Immunother | 2022 | 34269847 | PubTator, text mining | PubMed |
| Regulatory T-cell phenotypes in children with sickle cell disease. | Pediatr Res | 2022 | 34145401 | PubTator, text mining | PubMed |
| Successful treatment of hairy cell leukemia variant with obinutuzumab. | Ann Hematol | 2022 | 34086065 | PubTator, text mining | PubMed |
| Multiplexed digital spatial profiling of invasive breast tumors from Black and White women. | Mol Oncol | 2022 | 34018684 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=58